In vitro cellular drug sensitivity at diagnosis is correlated to minimal residual disease at end of induction therapy in childhood acute lymphoblastic leukemia.

G. Lönnerholm,I. Thörn,C. Sundström,B. Frost,J. Abrahamsson,M. Behrendtz,J. Heldrup,S. Jacobsson,Aihong Li,T. Olofsson,A. Porwit,S. Söderhäll,R. Larsson,E. Forestier
DOI: https://doi.org/10.1016/j.leukres.2008.06.012
Abstract:
What problem does this paper attempt to address?